A phase 1 randomized, placebo-controlled, single ascending dose study to examine the safety, tolerability, and pharmacokinetics of CP12 in healthy ad

Ended Cooperative Agreement Awarded Last action

Award ID
W81XWH1820059
Recipient
Awarding agency
Obligated
$2,194,516

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Lake Geneva, WI 53147, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment The purpose of this modification is to extend the period of performance by an additional 12 months, at no additional cost to the government, per request dated 7… $0
Original award $2,194,516

Quick answers

Who received award W81XWH1820059?

W81XWH1820059 was awarded to CAL Enterprises, LLC by Medical Command (Department of the Army) on September 30, 2018.

How much is award W81XWH1820059 worth?

$2,194,516 has been obligated on W81XWH1820059.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login